India to Egypt: Dacarbazine Export Trade Route
India has recorded 14 verified shipments of Dacarbazine exported to Egypt, representing a combined trade value of $47.8K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $3.4K USD. The leading Indian exporter is AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, which accounts for 72% of total export value with 9 shipments worth $34.4K USD. On the buying side, ROYAL PHARMA CO. is the largest importer in Egypt with $8.8K USD in purchases. The top 3 suppliers — AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, LIVEALTH BIOPHARMA PRIVATE LIMITED , RMPL PHARMA LLP — together control 93% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Egypt Dacarbazine corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $47.8K USD. The route is dominated by AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's dacarbazine manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $3.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with dacarbazine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 30.3%, placing it at rank #4 among India's top dacarbazine export destinations globally.
On the import side, key buyers of Indian dacarbazine in Egypt include ROYAL PHARMA CO., ROYAL PHARMA COMPANY, HANOVER MED CO and 7 others. ROYAL PHARMA CO. is the single largest importer with 2 shipments valued at $8.8K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#4
- Annual growth+30.3%
- Demand growth+27.2%
- Regulatory ease79/100
Top 10 Indian Dacarbazine Exporters to Egypt
Showing top 10 of 5 Indian suppliers exporting Dacarbazine to Egypt, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED Avg $3.8K per shipment | 9 | $34.4K | 71.9% |
| 2 | LIVEALTH BIOPHARMA PRIVATE LIMITED Avg $5.6K per shipment | 1 | $5.6K | 11.8% |
| 3 | RMPL PHARMA LLP Avg $4.4K per shipment | 1 | $4.4K | 9.3% |
| 4 | AARIA PHARMACEUTICALS PRIVATE LIMITED Avg $2.8K per shipment | 1 | $2.8K | 5.9% |
| 5 | J.A. UNITED EXPORTS PRIVATE LIMITED Avg $254 per shipment | 2 | $508 | 1.1% |
This table shows the top 10 of 5 Indian companies exporting dacarbazine to Egypt, ranked by total trade value. The listed exporters are: AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, LIVEALTH BIOPHARMA PRIVATE LIMITED , RMPL PHARMA LLP , AARIA PHARMACEUTICALS PRIVATE LIMITED, J.A. UNITED EXPORTS PRIVATE LIMITED. AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED is the dominant supplier with 9 shipments worth $34.4K USD, giving it a 72% market share. The top 3 suppliers together account for 93% of the total trade value on this route.
Top 10 Dacarbazine Importers in Egypt
Showing top 10 of 10 known buyers in Egypt receiving Dacarbazine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dacarbazine in Egypt include ROYAL PHARMA CO., ROYAL PHARMA COMPANY, HANOVER MED CO, TO THE ORDER,- , ROYAL PHARMA CO, among 10 total buyers. The largest importer is ROYAL PHARMA CO., accounting for $8.8K USD across 2 shipments — representing 18% of all dacarbazine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ROYAL PHARMA CO. | 2 | $8.8K | 18.5% |
| 2 | ROYAL PHARMA COMPANY | 2 | $6.5K | 13.6% |
| 3 | HANOVER MED CO | 2 | $5.7K | 12.0% |
| 4 | TO THE ORDER,- | 1 | $5.6K | 11.8% |
| 5 | ROYAL PHARMA CO | 1 | $5.1K | 10.7% |
| 6 | TO THE ORDER OF INVOICE RAISED TO | 1 | $4.4K | 9.3% |
| 7 | ROYAL MEDICAL AMREYA PUBLIC FREE | 1 | $4.3K | 9.0% |
| 8 | AL FARES FOR IMPORT AND | 1 | $3.9K | 8.1% |
| 9 | HAKIM FOR MEDICAL SUPPLIES | 1 | $2.8K | 5.9% |
| 10 | AL-NOOR FOR DRUGS & MEDICAL | 2 | $508 | 1.1% |
Top 10 Dacarbazine Formulations Imported by Egypt
Showing top 10 of 13 product formulations shipped on the India to Egypt Dacarbazine route, ranked by trade value
Egypt imports a wide range of dacarbazine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DACARBAZINE 200MG INJ.CELDAZ INJ.BN-DZI2414BC,MD-04/24,ED-03/27880PCS,BN-DZI2420BC,MD-06/24,ED-05/271788PCS AS PER INV — accounts for $6.7K USD across 1 shipments. There are 13 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DACARBAZINE 200MG INJ.CELDAZ INJ.BN-DZI2414BC,MD-04/24,ED-03/27880PCS,BN-DZI2420BC,MD-06/24,ED-05/271788PCS AS PER INV | 1 | $6.7K | 14.0% |
| 2 | DACARBAZINE 200MG INJ. CELDAZ 200 INJ.B. | 2 | $5.7K | 12.0% |
| 3 | Celdaz-500Inj.(Dacarbazine Inj.USP 500mg | 1 | $5.6K | 11.8% |
| 4 | DACARBAZINE 200MG INJ.CELDAZ INJ. BATCHNO.ALA2403DB, MFG.DT.01/2025, EXP.DT.12/2026 | 1 | $5.2K | 11.0% |
| 5 | CELDAZ INJ.DACARBAZINE 200MG INJ.BN:CBDC | 1 | $5.1K | 10.7% |
| 6 | DETIZENE 200MG(VIAL) (DACARBAZINE INJECT | 1 | $4.4K | 9.3% |
| 7 | DACARBAZINE 200MG INJ. B/N- DL230016 M/D | 1 | $4.3K | 9.0% |
| 8 | DACARBAZINE 200MG INJECTION.CELDAZ INJECTION. BATCH NO.ALA2404DB, MFG.DT.01/2025,EXP.DT.12/2026 | 1 | $3.9K | 8.1% |
| 9 | DECA 200MG (DACARBAZINE INJECTION I.P.)AS PER INVOICE AND PACKING LISTNOS | 1 | $2.8K | 5.9% |
| 10 | PHARMACEUTICAL PRODUCTS:- DACARBAZINE 200MG INJ. - B.NO. CBDCL2303YA, MFG DT. 09/23, EXP DT. 08/26 | 1 | $2.1K | 4.5% |
Showing top 10 of 13 Dacarbazine formulations imported by Egypt on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 4 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's dacarbazine exports to Egypt are driven primarily by a handful of large-scale manufacturers. AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Egypt benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, LIVEALTH BIOPHARMA PRIVATE LIMITED , RMPL PHARMA LLP — together account for 93% of total trade value on this route. The average shipment value of $3.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as dacarbazine 200mg inj. celdaz 200 inj.b. and celdaz-500inj.(dacarbazine inj.usp 500mg , suggesting that buyers in Egypt tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ROYAL PHARMA CO. is the largest importer with 2 shipments worth $8.8K USD — representing 18% of all dacarbazine imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $47.8K
- Avg. Shipment
- $3.4K
- Suppliers
- 5
- Buyers
- 10
- Transit (Sea)
- ~18 days
- Annual Growth
- +30.3%
Related Analysis
Other Dacarbazine Routes
Unlock the Full India to Egypt Dacarbazine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 14 shipments on this route.
Frequently Asked Questions — India to Egypt Dacarbazine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dacarbazine to Egypt?
The leading Indian exporters of Dacarbazine to Egypt are AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, LIVEALTH BIOPHARMA PRIVATE LIMITED , RMPL PHARMA LLP . AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED holds the largest market share at approximately 72% of total trade value on this route.
Q What is the total value of Dacarbazine exports from India to Egypt?
India exports Dacarbazine to Egypt worth approximately $47.8K USD across 14 recorded shipments. The average value per shipment is $3.4K USD.
Q Which ports does India use to ship Dacarbazine to Egypt?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 4 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Egypt for Dacarbazine?
The average transit time for Dacarbazine shipments from India to Egypt is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Egypt Dacarbazine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.3% with demand growth tracking at 27.2%. The route is ranked #4 among India's top Dacarbazine export destinations globally.
Q How many suppliers are active on the India to Egypt Dacarbazine route?
There are currently 5 active Indian suppliers exporting Dacarbazine to Egypt. The market is moderately concentrated with AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED accounting for 72% of total shipment value.
Q Who are the main importers of Dacarbazine from India in Egypt?
The leading importers of Indian Dacarbazine in Egypt include ROYAL PHARMA CO., ROYAL PHARMA COMPANY, HANOVER MED CO, TO THE ORDER,- , ROYAL PHARMA CO. ROYAL PHARMA CO. is the largest buyer with 2 shipments worth $8.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Egypt export trade corridor identified from Indian Customs (DGFT) records for Dacarbazine.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 10 importers in Egypt matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 14 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists